VE-1902

Verseon to Initiate Ph I Study of New Class Anticoagulant with Reduced Bleeding Risk
CP Wire
Thu, 06/14/18 - 09:48 am
Verseon
VE-1902
anticoagulants
Verseon to Initiate Ph I Study of New Class Anticoagulant with Reduced Bleeding Risk
Thu, 06/14/18 - 09:31 am
Verseon
VE-1902
anticoagulants